ORIA NASDAQ
Orion Biotech Opportunities Corp.
1W: +0.0%
1M: -0.3%
3M: +0.8%
1Y: +4.5%
$10.23
Last traded 2023-05-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$900K
-43.3% ▼
Net Income
$18M
+2342.6% ▲
EPS (Diluted)
$0.92
+2904.9% ▲
EBITDA
-$11M
-1358.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 |
|---|---|---|
| Revenue | $0 | $0 |
| YoY Growth | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Gross Margin | — | — |
| R&D Expenses | $0 | $0 |
| SG&A Expenses | $554K | $900K |
| Operating Expenses | $554K | $900K |
| Operating Income | -$628K | -$900K |
| Operating Margin | — | — |
| Interest Expense | $96K | $0 |
| Income Before Tax | -$724K | $9M |
| Tax Expense | $96K | -$10M |
| Net Income | -$821K | $18M |
| Net Margin | — | — |
| EPS (Diluted) | $-0.03 | $0.92 |
| EBITDA | -$724K | -$11M |
| Shares Outstanding | 19M | 20M |